Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1. Murrell JC, Hellebrekers LJ. Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive properties in the dog. Vet Anaesth Analg 2005;32:117–127.
-
2. Clarke KW, Trim CM, Hall LW. Principles of sedation, anticholinergic agents and principles of premedication. In: Clarke KW, Trim CM, Hall LW, eds. Veterinary anaesthesia. 11th ed. Edinburgh: Saunders Elsevier, 2014;79–100.
-
3. Pascoe PJ. Opioid analgesics. Vet Clin North Am Small Anim Pract 2000;30:757–772.
-
4. Mastrocinque S, Fantoni DT. A comparison of preoperative tramadol and morphine for the control of early postoperative pain in canine ovariohysterectomy. Vet Anaesth Analg 2003;30:220–228.
-
5. Vettorato E, Bacco S. A comparison of the sedative and analgesic properties of pethidine (meperidine) and butorphanol in dogs. J Small Anim Pract 2011;52:426–432.
-
6. Cardozo LB, Cotes LC, Kahvegian MA, et al. Evaluation of the effects of methadone and tramadol on postoperative analgesia and serum interleukin-6 in dogs undergoing orthopaedic surgery. BMC Vet Res 2014;10:194.
-
7. Ossipov MH, Harris S, Lloyd P, et al. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology 1990;73:1227–1235.
-
8. Salmenperä MT, Szlam F, Hug CC Jr. Anesthetic and hemodynamic interactions of dexmedetomidine and fentanyl in dogs. Anesthesiology 1994;80:837–846.
-
9. Jordan BA, Gomes I, Rios C, et al. Functional interactions between μ opioid and α2A-adrenergic receptors. Mol Pharmacol 2003;64:1317–1324.
-
10. Grint NJ, Burfor J, Dugdale AH. Does pethidine affect the cardiovascular and sedative effects of dexmedetomidine in dogs? J Small Anim Pract 2009;50:62–66.
-
11. Kellihan HB, Stepien RL, Hassen KM, et al. Sedative and echocardiographic effects of dexmedetomidine combined with butorphanol in healthy dogs. J Vet Cardiol 2015;17:282–292.
-
12. Cardoso CG, Marques DCR, Silva THM, et al. Cardiorespiratory, sedative and antinociceptive effects of dexmedetomidine alone or in combination with methadone, morphine or tramadol in dogs. Vet Anaesth Analg 2014;41:636–643.
-
13. Kuusela E, Raekallio M, Antilla M, et al. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J Vet Pharmacol Ther 2000;23:15–20.
-
14. Sabbe MB, Pening JP, Ozaki GT, et al. Spinal and systemic action of the α2 receptor agonist dexmedetomidine in dogs: antinociceptive and carbon dioxide response. Anesthesiology 1994;80:1057–1072.
-
15. Bell AM, Auckburally A, Pawson P, et al. Two doses of dexmedetomidine in combination with buprenorphine for premedication in dogs; a comparison with acepromazine and buprenorphine. Vet Anaesth Analg 2011;38:15–23.
-
16. Congdon JM, Marquez M, Niyom S. Evaluation of the sedative and cardiovascular effects of intramuscular administration of dexmedetomidine with and without concurrent atropine administration in dogs. J Am Vet Med Assoc 2011;239:81–89.
-
17. Maiante AA, Teixeira Neto FJ, Beier SL, et al. Comparison of the cardio respiratory effects of methadone and morphine in conscious dogs. J Vet Pharmacol Ther 2009;32:317–328.
-
18. Lemke KA. Anticholinergics and sedatives. In: Tranquilli WJ, Thurmon JC, Grimm KA. Lumb & Jones’ veterinary anesthesia and analgesia. 14th ed. Ames, Iowa: Blackwell Publishing, 2007;203–207.
-
19. Papich MG. Pharmacologic considerations for opiate analgesic and nonsteroidal anti-inflammatory drugs. Vet Clin North Am Small Anim Pract 2000;30:815–837.
-
20. Canfrán S, Bustamante P, González R, et al. Comparison of sedation scores and propofol induction doses in dogs after intramuscular administration of dexmedetomidine alone or in combination with methadone, midazolam, or methadone plus midazolam. Vet J 2016;210:56–60.
-
21. Raillard M, Michaut-Castrillo J, Spreux D, et al. Comparison of medetomidine-morphine and medetomidine-methadone for sedation, isoflurane requirement and postoperative analgesia in dogs undergoing laparoscopy. Vet Anaesth Analg 2017;44:17–27.
-
22. Hayashi Y, Sumikawa K, Maze M, et al. Dexmedetomidine prevents epinephrine induced arrhythmias through stimulation of central alpha two adrenoreceptors in halothane anesthetized dogs. Anesthesiology 1991;75:113–117.
-
23. Tobias JD, Chrysostomou C. Dexmedetomidine: antiarrhythmic effects in the pediatric cardiac patient. Pediatr Cardiol 2013;34:779–785.
-
24. Lin GY, Robben JH, Murrell JC, et al. Dexmedetomidine constant rate infusion for 24 hours during and after propofol or isoflurane anaesthesia in dogs. Vet Anaesth Analg 2008;35:141–153.
-
25. Sinclair MD. A review of the physiological effects of α-2-agonists related to the clinical use of medetomidine in small animal practice. Can Vet J 2003;44:885–897.
-
26. Gómez-Villamandos RJ1, Palacios C, BenÃtez A, et al. Dexmedetomidine or medetomidine premedication before propofol-desflurane anaesthesia in dogs. J Vet Pharmacol Ther 2006;29:157–163.
-
27. Santiago TV, Edelman NH. Opioids and breathing. J Appl Physiol 1985;59:1675–1685.
-
28. Sederberg J, Stanley TH, Reddy P, et al. Hemodynamic effects of butorphanol-oxygen anesthesia in dogs. Anesth Analg 1981;60:715–719.
-
29. McMillan CJ, Livingston A, Clark CR, et al. Pharmacokinetics of intravenous tramadol in dogs. Can J Vet Res 2008;72:325–331.
-
30. Pascoe PJ. The cardiopulmonary effects of dexmedetomidine infusions in dogs during isoflurane anaesthesia. Vet Anaesth Analg 2015;42:360–368.
-
31. Congdon JM, Marquez M, Niyom S, et al. Cardiovascular, respiratory, electrolyte and acid-base balance during continuous dexmedetomidine infusion in anesthetized dogs. Vet Anaesth Analg 2013;40:464–471.
-
32. Ko JCH, Fox SM, Mandsager RE. Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs. J Am Vet Med Assoc 2000;216:1578–1583.
-
33. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001;53:597–652.
Advertisement
Effects of dexmedetomidine combined with commonly administered opioids on clinical variables in dogs
Abstract
OBJECTIVE To evaluate cardiopulmonary, sedative, and antinociceptive effects of dexmedetomidine combined with commonly administered opioids in dogs.
ANIMALS 8 healthy Beagles.
PROCEDURES Dogs were sedated by IM administration of each of 7 treatments. Treatments comprised dexmedetomidine (0.01 mg/kg; Dex) and the same dose of dexmedetomidine plus butorphanol (0.15 mg/kg; Dex-But), meperidine (5 mg/kg; Dex-Mep), methadone (0.5 mg/kg; Dex-Meth), morphine (0.5 mg/kg; Dex-Mor), nalbuphine (0.5 mg/kg; Dex-Nal), or tramadol (5 mg/kg; Dex-Tram). Cardiorespiratory and arterial blood gas variables and sedative and antinociceptive scores were measured before drug injection (time 0; baseline) and at 15-minute intervals for 120 minutes.
RESULTS Heart rate was reduced at all time points after injection of Dex-But, Dex-Mep, Dex-Meth, and Dex-Mor treatments. There was a significant reduction of mean arterial blood pressure for Dex-But, Dex-Mep, and Dex-Mor treatments at all time points, compared with baseline. There was a significant decrease in respiratory rate, compared with the baseline value, for Dex, Dex-But, Dex-Meth, and Dex-Tram treatments from 15 to 120 minutes. A significant decrease in arterial blood pH was detected from baseline to 120 minutes for all treatments, with differences among Dex, Dex-Mep, and Dex-Mor. Reduction in Pao2 was greater for the Dex-Mep treatment than for the other treatments. The highest sedation scores were detected for Dex-Mep and Dex-Meth treatments. Antinociceptive effects were superior for Dex-But, Dex-Meth, Dex-Mor, and Dex-Nal treatments.
CONCLUSIONS AND CLINICAL RELEVANCE Drug combinations caused similar cardiorespiratory changes, with greater sedative effects for Dex-Mep and Dex-Meth and superior antinociceptive effects for Dex-But, Dex-Meth, Dex-Mor, and Dex-Nal.
Contributor Notes
Powered by PubFactory